2020-12-02
Camurus AB today announced that Camurus licensee Braeburn has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) regarding its new drug application (NDA) for Brixadi.
Read the full press release: https://www.camurus.com/
2018-07-19
The family owned investment company Sandberg Development invests in SWATAB (SCANDINAVIAN WATER TECHNOLOGY AB). The i…
Read more2018-06-29
On the 25th of May 2018 the new regulation in EU law on data protection and privacy for all individuals within the E…
Read more2018-01-31
Sandberg Development invests SEK 30 million in the Malmö-based water recycling technology Company Orbital Systems.
Read more2017-09-18
As part of our business concept - "Investing in innovations with growth in focus" - Sandberg Development has, during…
Read more2017-05-19
New data support long-term safety and efficacy of weekly and monthly subcutaneous buprenorphine depots in patients w…
Read more